Pedro C. Lara Jiménez

Jefe Departamento Oncología H.U. San Roque (Las Palmas)


1985 completion of medical studies at the University of Granada. Spain
1988 Ph.D. thesis University of Granada, Spain
1990 Radiation Oncology specialist Granada University Hospital,Spain
Professional experience/appointments:
1983-87 Research student/fellow Oncology Granada University Hospital, Spain 1987:1991Training in Radiation Oncology,Granada University Hospital, Spain
1987: Visiting trainee in Instituto de Tumori di Milano, Italy
1988: Visiting trainee in MD Anderson Cancer Center, USA
1990: Visiting trainee in Academisch Medisch Centrum, The Netherlands
1991-2008: Consultant Radiation Oncologist, Las Palmas University Hospital, Spain
1991-1995: Associate Professor of Radiation Oncology Las Palmas University, Spain
1995 Fellow Traslational Research, NKI, The Netherlands
1996: Full Professor of Radiation Oncology, Las Palmas University, Spain.
2001-onwards Member Canarian Institute for Cancer Research,Spain
2009-2018: Head, Radiation Oncology, Las Palmas University Hospital. Spain
2011-2016: President Ethic Committee Las Palmas University Hospital,Spain
2011-onwards: Director and Patron Canarian Institute for Cancer Research,Spain
2013-2018: Full Professor and Chair of Clinical Oncology and Hematology Las Palmas University,Spain .
2015-onwards: Director University Oncology Campus, SEOR/Francisco de Vitoria University Madrid Spain.
2018-onwards. Full Professor and Chair of Oncology and Radiotherapy Hematology Fernado Pessoa Canarias University ,Spain .
2018-onwards. Head, Oncology Dept, San Roque University Hospital. Spain
Professional membership & associations:
ASEICA(Spanish Assoc Cancer Research)
2008-12: Board of Directors
EACR (European Organization for Cancer Research)
ESTRO (European Society for Radiotherapy and Oncology)
2015-to date: ESTRO Grants Committee
2015-to date: ESTRO Clinical Committee Member
2015-to date: ESTRO National Societies Committee Member
2018-onwards: HERO-ESTRO Spain Initiative Member
EORTC (European Organization for Research and Treatment of Cancer)
2013-to date: EORTC Radiation Oncology, Gynecology, Urology Groups Member
2015-to date: Liason member steering committee GU group
2014:EORTC GYN Group Meeting Las Palmas Local Organizer
2015:EORTC ROG Group Meeting Las Palmas Local Organizer
2017:EORTC GU Group Meeting Las Palmas Local Organizer
SEOR (Spanish Society Radiation Oncology)
2013-2015: SEOR Vice-president
2015-17: SEOR President
2017-2019: SEOR: Past President
2017-Onwards: Director Oncology University Campus SEOR//Fancisco de Vitoria University.
SEOC: (Spanish Society Clinical Oncology)
2015-Onwards: SEOC. Founder
2015-Onwards: SEOC. Secretary
FESEO (Spanish Federation of Oncological Societies)
2017-2019. Vice-president
UEMS (European Union of Medical Specialties)
2016-Onwards: UEMS Spanish representative Radiation/Clinical Oncology
2018-Onwards.President UEMS Radiation/Clinical Oncology Group
Member of the editorial board of Radiation Oncology, Reports of Practical Oncology and Radiotherapy, Clinical Traslational Oncology and Clinical and Traslational Radiation Oncology journals. He is actively publishing and reviewing scientific articles for several journals and participating in national and international scientific, educational and research meetings.
(Pubmed Lara PC, also Lara P,Lara-Jimenez, PC) H Index WOS:23
2020 publications
1.- Hypofractionated whole breast irradiation after IORT treatment: evaluation of acute toxicity and cosmesis.Clin Transl Oncol. 2020 May 22. In press
2.-Low dose lung radiotherapy for COVID-19 pneumonia. The rationale for a cost-effective anti-inflammatory treatment. Clin Transl Radiat Oncol. 2020 Apr 25;23:27-29.
3.- Older Cancer Patients during the COVID-19 Epidemic: Practice Proposal of the International Geriatric Radiotherapy Group.Cancers (Basel). 2020 May 19;12(5):E1287.
4.-Accelerated partial breast irradiation with interstitial multicatheter brachytherapy after breast-conserving surgery for low-risk early breast cancer. Breast. 2020 Apr 22;52:45-49.
5.-EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort†: Under the Auspices of the EAU-ESMO Guidelines Committees. Eur Urol. 2020 Feb;77(2):223-250.